PLAY PODCASTS
James Hallifax, The Psychedelic Investor
Episode 47

James Hallifax, The Psychedelic Investor

James Hallifax, The Psychedelic Investor, shares the two things he looks at when evaluating a medicinal psychedelic company.

Psychedelic Spotlight Podcast · The Psychedelic Investor, David Flores, Global Trac Solutions Inc., Psychedelic Spotlight, James Hallifax

July 23, 202125m 23s

Audio is streamed directly from the publisher (cdn.simplecast.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

In this episode of the Psychedelic Spotlight podcast, we feature James Hallifax, Co-Founder of The Psychedelic Investor, an emerging media company covering the medicinal psychedelics space and partner of Psychedelic Spotlight. 

In our conversation with James, we talk about what led him to launching The Psychedelic Investor, the potential he sees in the medicinal psychedelics industry, and what companies within this space he is currently paying close attention to and why. 

*Make sure you subscribe to The Psychedelic Investor on YouTube and visit their site at: ThePsychedelicInvestor.com

*Subscribe to our newsletter to get the latest industry news around all things psychedelics: PsychedelicSpotlight.com

Instagram: @PsycSpotlight

Twitter: @PsycSpotlight

Facebook: PsychedelicSpotlight

YouTube: PsychedelicSpotlight

LinkedIn: Psychedelic-Spotlight

 

*This interview was recorded on July 14, 2021.

Topics

david floresmdmaglobal trac solutions incthe psychedelic investorpsychedelic-assisted psychotherapyjames hallifaxpsychotherapistayahuascaketaminepsychotherapymeditationmushroomsyogashroomsmagic shroomsmental healthinvestmentshealthpsilocybinpsychedelic spotlightketamine-assisted psychotherapyplant medicinepsychedelics